Durable response with medroxiprogesterone acetate in metastatic renal cell carcinoma: Case report

Durable response with medroxiprogesterone acetate in metastatic renal cell carcinoma: Case report

Bibliographic Details
Main Authors:	Bekir Muhammet Hacioglu, Osman Kostek, Bulent Erdogan, Hilmi Kodaz, Ilhan Hacibekiroglu, Esma Turkmen, Sernaz Uzunoglu, Irfan Cicin
Format:	Article
Language:	English
Published:	Turkiye Klinikleri 2016-08-01
Series:	Journal of Oncological Sciences
Online Access:	http://www.sciencedirect.com/science/article/pii/S2452336416300346

Similar Items

Clinical features of the patient with multiple primary tumors: Single center experience
by: Ali Gökyer, et al.
Published: (2017-05-01)

KRAS Mutation in Small Cell Lung Carcinoma and Extrapulmonary Small Cell Cancer
by: Hilmi Kodaz, et al.
Published: (2016-08-01)

A Small Cell Carcinoma in the Testis Associated with Testicular Teratoma
by: Esma Türkmen, et al.
Published: (2014-06-01)

Endometrial carcinoma and paraneoplastic immune thrombocytopenia
by: Hilmi Kodaz, et al.
Published: (2016-04-01)

A retrospective study on potential drug interactions: A single center experience
by: Fatma Ceyda Korucu, et al.
Published: (2018-08-01)

PNI as a Potential Add-On Biomarker to Improve the IMDC Intermediate Prognostic Score
by: İbrahim Vedat Bayoğlu, et al.
Published: (2023-10-01)

Molecular Pattern and Clinical Implications of KRAS/NRAS and BRAF Mutations in Colorectal Cancer
by: İvo Gökmen, et al.
Published: (2023-09-01)

Treatment Outcomes of Metastatic Colorectal Cancer Patients Treated with Regorafenib as Third-Line Setting-A Multicenter Study
by: Süleyman Şahin, et al.
Published: (2019-03-01)

Treatment Outcomes of HER-2 Positive Metastatic Breast Cancer Patients Treated with Pertuzumab in the First Line Setting- Real Life Experience
by: Bekir Hacioglu, et al.
Published: (2019-04-01)

Enzalutamide versus Abiraterone Acetate as first-line treatment of castration resistant metastatic prostate cancer in geriatric (≥75) patients
by: Ali Alkan, et al.
Published: (2021-09-01)

An Unusual Presentation of Merkel Cell Carcinoma
by: Kamuran İbiş, et al.
Published: (2012-03-01)

Predictive and Prognostic Factors in Ovarian and Uterine Carcinosarcomas
by: İrfan Cicin, et al.
Published: (2016-10-01)

YDS Arapça Sınavına Dair Bazı Tespit ve Öneriler (2013-2018)
by: Muhammet Mücahit Asutay, et al.
Published: (2021-12-01)

Strength and durability characteristics of polymer modified concrete incorporating vinyl acetate effluent
by: Noruzman, A. H., et al.
Published: (2013)

The Effect of Prognostic Nutritional Index on Prognosis in Small Cell Lung Cancer: Single Center Experience
by: Esma TÜRKMEN BEKMEZ
Published: (2020-08-01)

THE ACCESS RATE TO DIAGNOSIS AND TREATMENT MODALITIES IN BREAST CANCER PATIENTS IN TURKEY; MULTICENTER OBSERVATIONAL STUDY
by: Pınar Saip, et al.
Published: (2011-04-01)

Feasibility of abiraterone acetate treatment in patients with metastatic castration-resistant prostate cancer and atrial fibrillation
by: Simon Rauch, et al.
Published: (2016-06-01)

BRAF V600 Mutation Profile of Metastatic Melanoma in the Thrace Region of Turkey
by: Nuray CAN, et al.
Published: (2018-05-01)

Cancer-related hypercalcemia and potential treatments
by: Elvina Almuradova, et al.
Published: (2023-03-01)

Effect of clinical and pathological features of gastrointestinal stromal tumors on overall survival and prognosis: Single center experience
by: Elif Merev, et al.
Published: (2019-12-01)

Durability effect of reclaimed asphalt aggregate on concrete road pavement
by: Tayfun Uygunoğlu, et al.
Published: (2024-03-01)

Primer Vezikoüreteral Reflüde Renal Kortikal Anormallik ve İdrar Yolu Enfeksiyonu İlişkisinin Değerlendirilmesi
by: Esma Keleşalp, et al.
Published: (2021-01-01)

Abigene, a Prospective, Multicentric Study of Abiraterone Acetate Pharmacogenetics in Metastatic Castration-Resistant Prostate Cancer
by: Jean-Marc Ferrero, et al.
Published: (2023-02-01)

Comparing the Efficacy of GnRH Agonists on the Castration Levels of Metastatic Prostate Cancer; Leuprolide Acetate 22.5 mg vs. Goserelin Acetate 10.8 mg
by: Gökhan Çil, et al.
Published: (2023-06-01)

Antitumor immunity as the basis for durable disease-free treatment-free survival in patients with metastatic urothelial cancer
by: Huan Wang, et al.
Published: (2023-08-01)

Baş Boyun Kanseri Hastalarının Klinik Özellikleri ve Tedavi Sonuçlarının Değerlendirilmesi: Tek Merkez Deneyimi
by: Ceyhun Varım, et al.
Published: (2021-03-01)

The use of volatile compounds as an alternative method in pepper breeding (Capsicum baccatum var. pendulum)
by: Kazım Mavi, et al.
Published: (2021-08-01)

Concomitant antihypertensive medication and outcome of patients with metastatic castration‐resistant prostate cancer receiving enzalutamide or abiraterone acetate
by: Ondřej Fiala, et al.
Published: (2024-01-01)

Abiraterone acetate and prednisone in metastatic castration-resistant prostate cancer: a real-world retrospective study in China
by: Min Liu, et al.
Published: (2023-05-01)

Arap Dilinde 'Edatların Anlamı' Sorunu
by: Abdullah Hacıbekiroğlu
Published: (2022-07-01)

İBNU’D-DÂİ‘ VE ARAP DİLİNE KATKILARI
by: Abdullah Hacıbekiroğlu
Published: (2017-12-01)

ONC201/TIC10 enhances durability of mTOR inhibitor everolimus in metastatic ER+ breast cancer
by: Elena Farmaki, et al.
Published: (2023-09-01)

Body composition parameters were associated with response to abiraterone acetate and prognosis in patients with metastatic castration‐resistant prostate cancer
by: Zhi‐Bin Ke, et al.
Published: (2023-04-01)

Progress in A Real-world Study of Abiraterone Acetate Versus Docetaxel in Patients with Metastatic Hormone-sensitive Prostate Cancer
by: MA Dongsheng, et al.
Published: (2023-05-01)

Real-life data of abiraterone acetate and enzalutamide treatment in post-chemotherapy metastatic castration-resistant prostate cancer in Poland
by: Dawid Sigorski, et al.
Published: (2023-04-01)

Survival outcomes and prognostic factors for first-line abiraterone acetate or enzalutamide in patients with metastatic castration-resistant prostate cancer
by: Chi-Shin Tseng, et al.
Published: (2023-06-01)

The Prognostic Significance of Thymidine Kinase Activity Levels In Metastatic Colorectal Cancer
by: Erdoğan Selçuk ŞEBER
Published: (2016-12-01)

A durable complete response resulting from treatment with nivolumab plus ipilimumab for metastatic collecting duct carcinoma of the kidney
by: Keisuke Funajima, et al.
Published: (2023-07-01)

Comparison of alternative methods for methyl acetate + methanol + acetic acid + acetic anhydride mixture separation
by: A. V. Frolkova, et al.
Published: (2019-11-01)

Durable complete response to neoantigen-loaded dendritic-cell vaccine following anti-PD-1 therapy in metastatic gastric cancer
by: Zengqing Guo, et al.
Published: (2022-06-01)